Mary Talley Bowden, M.D.
Sleep Medicine (Otolaryngology) Physician · Houston, TX
Mary Talley Bowden, M.D. is a sleep medicine (otolaryngology) physician with a practice address in Houston, Texas, and NPI 1699858282, issued on Oct 24, 2006. Check the license (Texas K9770, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Mary Talley Bowden
- Credential
- M.D.
- Primary taxonomy
- Sleep Medicine (Otolaryngology) Physician 207YS0012X
- License number
- K9770 TX
Self-reported in NPPES; status is on the state search - Practice location
- 3600 Kirby Dr Ste F, Houston, TX 77098
- Phone
- (713) 492-2340
- Enumerated
- Oct 24, 2006
- Record last updated
- Aug 29, 2019 (not updated in 7 years: call before relying on the address or phone)
- Fax
- (713) 510-1912
- Medicare enrollment
- Enrolled (PECOS I20040420000166); may accept Medicare assignment
- Medical or professional school
- Medical College Of Georgia School Of Medicine, 1998
- Entity
- Type 1 · individual
Verify Mary Talley Bowden in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license K9770Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
About as many Medicare Part D claims as the average sleep medicine (otolaryngology) physician in 2024
290 Medicare Part D claims for 125 beneficiaries, against an average of 290 among the 46 providers of this specialty who prescribed in Part D.
Most prescribed
- Azithromycin48 claims
- Amoxicillin-Clavulanate Potass40 claims
- Hydroxychloroquine Sulfate35 claims
- Doxycycline Hyclate19 claims
- Methylprednisolone17 claims
- Mupirocin16 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Sleep Medicine (Otolaryngology) Physician providers in Texas
There are 5 sleep medicine (otolaryngology) physician records in Texas.
Other sleep medicine (otolaryngology) physician records in Texas
- Arunkumar Badi, MD, PHDDallas, TX1225123938
- Ahmed Beydoun, MDHouston, TX1851929418
- Nici Bothwell, MDSan Antonio, TX1033195417
- Kevin Lin, MDHouston, TX1043707714
Common questions
What is Mary Talley Bowden, M.D.'s NPI number?
Mary Talley Bowden, M.D.'s National Provider Identifier (NPI) is 1699858282, issued on Oct 24, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Mary Talley Bowden, M.D. located?
The NPPES record lists a practice address at 3600 Kirby Dr Ste F, Houston, TX, 77098. Phone: (713) 492-2340. Providers update this record themselves, so call before visiting.
How can I verify Mary Talley Bowden, M.D.'s license?
NPPES lists Texas license number K9770, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Mary Talley Bowden, M.D. prescribe under Medicare Part D?
In 2024, Mary Talley Bowden, M.D. had 290 Medicare Part D claims for 125 beneficiaries; the average among sleep medicine (otolaryngology) physician prescribers was 290. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.